Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria
van der Linden S et al. (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361-368
International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001
Petty RE et al. (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J Rheumatol 31: 390-392
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
Dougados M et al. (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34: 1218-1227
Evaluation of four sets of criteria for spondyloarthropathy in children: A multicenter cross-sectional European study [abstract]
Prieur AM et al. (1992) Evaluation of four sets of criteria for spondyloarthropathy in children: A multicenter cross-sectional European study [abstract]. Arthritis Rheum 35 (suppl): S190
Eds Weisman MH et al, Philadelphia: Mosby Elsevier
Burgos-Vargas R (2006) The juvenile onset spondyloarthritides. In Ankylosing spondylitis and the spondyloarthropathies, 96-106 (Eds Weisman MH et al.) Philadelphia: Mosby Elsevier
The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for Rheumatology
Burgos-Vargas R et al. (2002) The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for Rheumatology. J Rheumatol 29: 869-874
The influence of heredity for psoriasis on the ILAR classification of juvenile idiopathic arthritis
Berntson L et al. (2002) The influence of heredity for psoriasis on the ILAR classification of juvenile idiopathic arthritis. J Rheumatol 29: 2454-2458
Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001)
Merino R et al. (2005) Evaluation of revised International League of Associations for Rheumatology classification criteria for juvenile idiopathic arthritis in Spanish children (Edmonton 2001). J Rheumatol 32: 559-561
Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis
Stoll ML et al. (2008) Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis. Arthritis Rheum 59: 51-58
The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis
Burgos-Vargas R and Vázquez-Mellado J (1995) The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis. Arthritis Rheum 38: 835-844
Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria
Rudwaleit M et al. (2006) Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 54: 569-578
Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children with juvenile arthritides
Bollow M et al. (1998) Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children with juvenile arthritides. J Rheumatol 25: 556-564
Efficacy, safety, and tolerability of infliximab in juvenile-onset spondyloarthropathies (JO-SpA): Results of the threemonth, randomized, double-blind, placebo-controlled trial phase
Burgos-Vargas R et al. (2007) Efficacy, safety, and tolerability of infliximab in juvenile-onset spondyloarthropathies (JO-SpA): Results of the threemonth, randomized, double-blind, placebo-controlled trial phase. Arthritis Rheum 56 (suppl): S319